Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.270 EUR
−9.11 M EUR
428.72 M EUR
18.96 M
About ION BEAM APPLICATIONS
Sector
Industry
CEO
Olivier Legrain
Website
Headquarters
Louvain-la-Neuve
Founded
1986
ISIN
BE0003766806
FIGI
BBG000GCNF51
Ion Beam Applications SA engages in the design, manufacture, and marketing of cancer treatment and diagnosis equipment. It operates through the Proton Therapy and Other Accelerators; and Dosimetry segments. The Proton Therapy and Other Accelerators segment include development, fabrication, and services associated with medical and industrial particle accelerators and proton therapy systems. The Dosimetry segment comprises activities that offer a full range of solutions and services that maximize efficiency and minimize errs in radiation therapy and medical imaging quality assurance and calibration procedures. The company was founded by Yves Jongen on March 28, 1986 and is headquartered in Louvain-la-Neuve, Belgium.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange Ion Beam Applications S.A. IBA stocks are traded under the ticker IOB.
We've gathered analysts' opinions on Ion Beam Applications S.A. IBA future price: according to them, IOB price has a max estimate of 21.40 EUR and a min estimate of 14.50 EUR. Watch IOB chart and read a more detailed Ion Beam Applications S.A. IBA stock forecast: see what analysts think of Ion Beam Applications S.A. IBA and suggest that you do with its stocks.
Yes, you can track Ion Beam Applications S.A. IBA financials in yearly and quarterly reports right on TradingView.
Ion Beam Applications S.A. IBA is going to release the next earnings report on Mar 20, 2025. Keep track of upcoming events with our Earnings Calendar.
IOB earnings for the last half-year are −0.34 EUR per share, whereas the estimation was −0.12 EUR, resulting in a −183.33% surprise. The estimated earnings for the next half-year are 0.58 EUR per share. See more details about Ion Beam Applications S.A. IBA earnings.
Ion Beam Applications S.A. IBA revenue for the last half-year amounts to 206.25 M EUR, despite the estimated figure of 211.00 M EUR. In the next half-year revenue is expected to reach 260.35 M EUR.
IOB net income for the last half-year is −10.30 M EUR, while the previous report showed 18.15 M EUR of net income which accounts for −156.75% change. Track more Ion Beam Applications S.A. IBA financial stats to get the full picture.
Yes, IOB dividends are paid annually. The last dividend per share was 0.12 EUR. As of today, Dividend Yield (TTM)% is 0.93%. Tracking Ion Beam Applications S.A. IBA dividends might help you take more informed decisions.
As of Nov 15, 2024, the company has 1.99 K employees. See our rating of the largest employees — is Ion Beam Applications S.A. IBA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Ion Beam Applications S.A. IBA EBITDA is 38.51 M EUR, and current EBITDA margin is 4.18%. See more stats in Ion Beam Applications S.A. IBA financial statements.
Like other stocks, IOB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ion Beam Applications S.A. IBA stock right from TradingView charts — choose your broker and connect to your account.